Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,450.00
0.00 (0.00%)
At close: Feb 19, 2026
-1.09% (1Y)
| Market Cap | 60.35B -0.7% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 11.14M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 185.00 (3.39%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 300,116 |
| Average Volume | 222,555 |
| Open | 5,240.00 |
| Previous Close | n/a |
| Day's Range | 5,200.00 - 5,730.00 |
| 52-Week Range | 4,355.00 - 7,690.00 |
| Beta | n/a |
| RSI | 50.67 |
| Earnings Date | Nov 27, 2025 |